NTBL: Notable Labs Ltd Kompaniya qiymatining sof foydaga nisbati

Notable Labs Ltd - NTBL emitenti grafik logotipi

Notable Labs, Ltd. (NTBL) terapiya tanlash uchun istiqbolli AI platformasini yaratishda ma'lumotlar olimlari va onkologlarning tajribasini birlashtiradi. Biznes bashorat qiluvchi dasturiy ta'minotga tayangan bo'lsa-da, uning tashqi moliyalashtirish va tartibga soluvchi organlarga bog'liqligi spekulyativ elementni qo'shadi. Aksiyalar narxlarining ushbu grafigi, bunda ko'rsatkich -0.30 darajasida turibdi, YaIMdan mustaqil bo'lgan va buning o'rniga klinik muvaffaqiyatga bog'langan sikllilikni tasdiqlaydi.

Narx-foyda koeffitsiyenti: Notable Labs, Ltd. (NTBL) 21.02.2024 - 30.09.2024 uchun

Notable Labs Inc. (NTBL) boʻyicha keng qamrovli koʻrsatkichlar kesimi va tahlil

- aksiya kursi va ekspertlarning narx prognozi:
Narxlar dinamikasi grafigi notablelabs.com|NTBL - Konsensus maqsadli narx
- bozor kapitallashuvi haqida ma'lumot:
Bozor qiymati Notable Labs, Ltd.|NTBL - Korxona qiymati
- buxgalteriya balansi bo'yicha sof aktivlar qiymati ko'rsatkichlari:
Bitta aksiya uchun buxgalteriya qiymati Notable Labs|NTBL - Kompaniyaning sof aktivlari|Bozor kapitallashuvining balans qiymatiga nisbati notablelabs.com|NTBL - Kompaniyaning jami aktivlari
- qarzlar va to'lov qobiliyati haqida ma'lumot:
Barcha qarzlarning o‘z mablag‘lariga nisbati Notable Labs, Ltd.|NTBL - Uzoq muddatli qarzning kapitalga nisbati|Qisqa muddatli majburiyatlarning kapitalga nisbati Notable Labs Corp|NTBL - Kompaniya qarzlari|Qarzning balans qiymatiga nisbati Notable Labs, Ltd.|NTBL - Kompaniyaning uzoq muddatli qarzi|Qisqa muddatli qarz Notable Labs|Oraliq likvidlik koeffitsiyenti notablelabs.com
- kompaniyaning daromadliligi va baholash multiplikatorlari ko'rsatkichlari:
NTBL - Sof foyda|Prognoz qilingan kelajakdagi foyda Notable Labs, Ltd.|NTBL - P/E multiplikatori|Kelajakdagi narxning foydaga nisbati Notable Labs Ltd|NTBL - Narxning foydaga va o‘sish sur’atiga nisbati|Korxona qiymatining foizlar, soliqlar va amortizatsiyadan oldingi foydaga nisbati Notable Labs, Ltd.|NTBL - EBITDA operatsion foydasi|So'nggi o'n ikki oy davomida bitta aksiya uchun sof foyda Notable Labs|NTBL - So'nggi 12 oy davomida bir aksiya uchun sof foyda|So'nggi 12 oy davomida bitta aksiya uchun foydaning yillik o'sishi notablelabs.com|NTBL - Joriy yilda bir aksiya uchun foyda o'sishi|Keyingi yil uchun bir aksiya uchun sof foyda o'sishi prognozi Notable Labs, Ltd.
- emitentning tushumi va sotuvlari tafsilotlari:
NTBL - Daromad va sotish hajmi|Prognoz qilingan sotish hajmi notablelabs.com|NTBL - P/S multiplikatori|Narxning prognoz qilingan daromadga nisbati Notable Labs, Ltd.
Kompaniyaning har tomonlama tahlili:notablelabs.com NTBL
Notable Labs yetakchi tovari

Notable Labs, Ltd. (NTBL) terapiyani optimallashtirish uchun aniq qon saratoni diagnostikasiga AI texnologiyalarini integratsiya qilmoqda. P/E koeffitsiyenti shakllantirilgan sof foyda orqali biznesning bozor qiymati qoplangan davrini belgilaydi. Ushbu ko'rsatkichning oshishi bozor kutuvlarining ortiqchaligidan dalolat bersa, pasayishi aktivlarning past baholanganini anglatadi. P/E koeffitsiyenti tarixini tahlil qilish adolatli qiymat diapazonini aniqlash imkonini beradi. Ushbu grafikning yuqori chegarasidan oshish kompaniyaning kelajakdagi muvaffaqiyati uchun haddan tashqari ko'p to'lash xavfini tug'diradi.

Raqobatdosh kompaniyalar tahlili

ONC: Kompaniya qiymatining sof foydaga nisbati|Narx-foyda koeffitsiyenti HALO (Halozyme)|RVMD (Revolution Medicines Inc) - Kompaniya qiymatining sof foydaga nisbati|P/E multiplikatori AAPG (Ascentage)|CGON - Narx-foyda koeffitsiyenti|URGN: Narx-foyda koeffitsiyenti|BCAX - P/E multiplikatori|Personalis (PSNL) - Narxning foydaga nisbati|Erasca Inc - Kompaniya qiymatining sof foydaga nisbati|DCTH (Delcath) - P/E multiplikatori|Kapitalizatsiyaning foydaga nisbati Y-mAbs Corp YMAB|Narxning foydaga nisbati Aura Biosciences, Inc. (AURA)|candeltx.com - Narx-foyda multiplikatori|Narxning foydaga nisbati Accuray ARAY|SELLAS Life Sciences Group, Inc. (SLS) - Kapitalizatsiyaning foydaga nisbati|ACTU: Narx-foyda koeffitsiyenti|Citius Oncology Inc - Bozor narxining sof foydaga nisbati|HURA: P/E multiplikatori|protaratx.com (TARA) - P/E multiplikatori|FATE (Fate Therapeutics) - P/E multiplikatori|Narxning foydaga nisbati WHWK|Narxning foydaga nisbati TScan Therapeutics (TCRX)|Narxning foydaga nisbati CSBR (championsoncology.com)|P/E multiplikatori XBIT (XBiotech)|CEL-SCI Corp. (CVM) - Kapitalizatsiyaning foydaga nisbati|OSTX: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati RADX (radiopharmtheranostics.com)|artivabio.com (ARTV) - Narxning foydaga nisbati|ANL (Adlai Nortye) - Narxning foydaga nisbati|VERU (Veru Inc.) - P/E multiplikatori|P/E multiplikatori tempesttx.com|P/E multiplikatori XLO|Narxning foydaga nisbati RENB (renovarobio.com)|Narxning foydaga nisbati Mural Oncology MURA|Biznesning o‘zini qoplash muddati Kairos Pharma Limited (KAPA)|OKUR: Narx-foyda koeffitsiyenti|Kompaniya qiymatining sof foydaga nisbati GDTC (CytoMed Therapeutics)|curis.com (CRIS) - Narxning foydaga nisbati|APLM (Apollomics) - Narxning foydaga nisbati|Narx-foyda koeffitsiyenti THAR|ADVB (Advanced Biomed Corp) - Bozor narxining sof foydaga nisbati|P/E multiplikatori GNPX|calidibio.com - Narx-foyda multiplikatori|Sunshine Biopharma, Inc. - Narx-foyda koeffitsiyenti|Biznesning o‘zini qoplash muddati Xenetic Biosciences Inc. (XBIO)|SLRX - Narxning foydaga nisbati|PPBT (Kitov Pharma) - Narx-foyda multiplikatori|AONC (aoncology.com) - Narx-foyda koeffitsiyenti|BGNE: Bozor narxining sof foydaga nisbati|CKPT (Checkpoint Therapeutics, Inc.) - P/E multiplikatori|Narxning foydaga nisbati ELEV|Narxning foydaga nisbati iCAD, Inc. (ICAD)|Narxning foydaga nisbati IKNA (ikenaoncology.com)|P/E multiplikatori VIRX (Viracta Therapeutics, Inc.)|MOR - Narx-foyda koeffitsiyenti|NAYA Biosciences Inc. - P/E multiplikatori|AAPGV - P/E multiplikatori